Market Overview:
The global single-use technology for biopharmaceuticals market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biopharmaceuticals, technological advancements in single-use technology, and growing awareness about the benefits of using single-use technology. The protective clothing segment is expected to lead the global single-use technology for biopharmaceuticals market during the forecast period. This can be attributed to the increasing demand for protective clothing from hospitals and clinics across the globe due to rising concerns about cross contamination and infection control. The syringes, pipettes and pipette tips segment is also expected to witness high growth during the forecast period owing to its growing use in laboratories for performing various experiments and tests.
Product Definition:
Single-Use Technology for Biopharmaceuticals is a type of technology that is used to manufacture biopharmaceuticals. It is important because it helps to improve the quality and consistency of the biopharmaceuticals that are produced.
Protective Clothing:
Protective clothing, also known as cleanroom clothing or biosafety gear, is used by healthcare workers to protect themselves from hazardous biological materials. The global protective clothing market size was valued at USD 1.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Increasing R&D activities in biotechnology and pharmaceutical industries are anticipated to drive the demand for protective clothing over the forecast period.
Syringes:
A syringe is a hollow cylindrical container, which is used for the transfer of liquid or semi-liquid substances. The size of the syringe varies according to its use; small ones are used for injectable medicines and large ones are used in chemistry class to measure things like pH levels and volumes.
Application Insights:
Based on the application, the market is segmented into hospitals, clinics, and others. Hospitals dominate this market owing to their central location in healthcare facilities and easy access to patients. Single-use technologies help reduce contamination risk as well as improve patient safety by reducing human errors during drug preparation or usage procedures. These factors are likely to drive the segment over the forecast period.
Clinics also hold promising growth prospects due to their ability to serve a large number of patients with limited space availability at hospitals or other medical centers. Moreover, these sites offer convenient accessibility for people with less physical strength; thus driving demand over the forecast period. The others application segment includes pharmacies and laboratories that perform diagnostic tests using biohazardous materials or samples containing infectious agents that require single-use technology for protection of workers against cross-contamination and exposure risks respectively (NIBSC).
Regional Analysis:
North America dominated the global single-use technology for biopharmaceuticals market with a revenue share of over 35.0% in 2017. This is due to the presence of major players, advanced healthcare infrastructure, and high adoption rate for new technologies in this region. Moreover, increasing R&D expenditure by around 7% every year on average since 2010 has resulted in higher penetration of these products across this region as compared to other regions.
Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to factors such as rising number of clinical trials and biopharmaceutical companies investing more aggressively across this region along with growing medical tourism industry which caters primarily to Asian countries’ demand for quality healthcare services at affordable costs coupled with favorable government policies & regulations favoring investments from public and private entities within Asia Pacific Economic Cooperation (APEC) framework especially China & India are some prime attracting factors driving regional growth particularly within emerging markets such as China & India).
Growth Factors:
- Increasing demand for biopharmaceuticals: The global market for biopharmaceuticals is expected to grow at a CAGR of 10.8% from 2016 to 2021, reaching a value of 2.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising awareness about preventive healthcare, and technological advancements in the field of biotechnology.
- Growing preference for single-use technology: Single-use technology offers several advantages over traditional technologies such as reduced risk of cross contamination, improved product quality, and shorter turnaround time. These advantages are driving the adoption of single-use technology in the biopharmaceutical industry.
- Proliferation of contract manufacturing organizations (CMOs): The number of CMOs is growing rapidly due to the increasing demand for contract manufacturing services from pharmaceutical and biotech companies worldwide. This is resulting in increased competition among CMOs and drives down prices for contract manufacturing services offered by them further fuelling market growth .
Scope Of The Report
Report Attributes
Report Details
Report Title
Single-Use Technology for Biopharmaceuticals Market Research Report
By Type
Protective Clothing, Syringes, Pipettes and Pipette Tips, Flasks, Dishes, Sample and Centrifuge Vials, Simple Cultivation Systems
By Application
Hospitals, Clinics, Others
By Companies
Applikon Biotechnology, BioPure Technology, DowDuPont, EMD Millipore, GE Healthcare, Novasep, Pall, Saint-Gobain, Sartorius, Thermo Fisher Scientific, W. L. Gore and Associates
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Single-Use Technology for Biopharmaceuticals Market Report Segments:
The global Single-Use Technology for Biopharmaceuticals market is segmented on the basis of:
Types
Protective Clothing, Syringes, Pipettes and Pipette Tips, Flasks, Dishes, Sample and Centrifuge Vials, Simple Cultivation Systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Applikon Biotechnology
- BioPure Technology
- DowDuPont
- EMD Millipore
- GE Healthcare
- Novasep
- Pall
- Saint-Gobain
- Sartorius
- Thermo Fisher Scientific
- W. L. Gore and Associates
Highlights of The Single-Use Technology for Biopharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Protective Clothing
- Syringes
- Pipettes and Pipette Tips
- Flasks, Dishes, Sample and Centrifuge Vials
- Simple Cultivation Systems
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Single-Use Technology for Biopharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Single-use technology is a process or product that can only be used once. This type of technology is often used in biopharmaceuticals because it helps to reduce the risk of contamination and waste.
Some of the key players operating in the single-use technology for biopharmaceuticals market are Applikon Biotechnology, BioPure Technology, DowDuPont, EMD Millipore, GE Healthcare, Novasep, Pall, Saint-Gobain, Sartorius, Thermo Fisher Scientific, W. L. Gore and Associates.
The single-use technology for biopharmaceuticals market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Single-Use Technology for Biopharmaceuticals Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Single-Use Technology for Biopharmaceuticals Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Single-Use Technology for Biopharmaceuticals Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Single-Use Technology for Biopharmaceuticals Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Single-Use Technology for Biopharmaceuticals Market Size & Forecast, 2020-2028
4.5.1 Single-Use Technology for Biopharmaceuticals Market Size and Y-o-Y Growth
4.5.2 Single-Use Technology for Biopharmaceuticals Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Protective Clothing
5.2.2 Syringes
5.2.3 Pipettes and Pipette Tips
5.2.4 Flasks
5.2.5 Dishes
5.2.6 Sample and Centrifuge Vials
5.2.7 Simple Cultivation Systems
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Single-Use Technology for Biopharmaceuticals Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Single-Use Technology for Biopharmaceuticals Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Protective Clothing
9.6.2 Syringes
9.6.3 Pipettes and Pipette Tips
9.6.4 Flasks
9.6.5 Dishes
9.6.6 Sample and Centrifuge Vials
9.6.7 Simple Cultivation Systems
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Protective Clothing
10.6.2 Syringes
10.6.3 Pipettes and Pipette Tips
10.6.4 Flasks
10.6.5 Dishes
10.6.6 Sample and Centrifuge Vials
10.6.7 Simple Cultivation Systems
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Protective Clothing
11.6.2 Syringes
11.6.3 Pipettes and Pipette Tips
11.6.4 Flasks
11.6.5 Dishes
11.6.6 Sample and Centrifuge Vials
11.6.7 Simple Cultivation Systems
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Protective Clothing
12.6.2 Syringes
12.6.3 Pipettes and Pipette Tips
12.6.4 Flasks
12.6.5 Dishes
12.6.6 Sample and Centrifuge Vials
12.6.7 Simple Cultivation Systems
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Protective Clothing
13.6.2 Syringes
13.6.3 Pipettes and Pipette Tips
13.6.4 Flasks
13.6.5 Dishes
13.6.6 Sample and Centrifuge Vials
13.6.7 Simple Cultivation Systems
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Single-Use Technology for Biopharmaceuticals Market: Competitive Dashboard
14.2 Global Single-Use Technology for Biopharmaceuticals Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Applikon Biotechnology
14.3.2 BioPure Technology
14.3.3 DowDuPont
14.3.4 EMD Millipore
14.3.5 GE Healthcare
14.3.6 Novasep
14.3.7 Pall
14.3.8 Saint-Gobain
14.3.9 Sartorius
14.3.10 Thermo Fisher Scientific
14.3.11 W. L. Gore and Associates
